Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1966 5
1967 6
1968 3
1969 7
1970 11
1971 6
1972 8
1973 4
1974 6
1975 6
1976 12
1977 6
1978 3
1979 18
1980 14
1981 11
1982 9
1983 5
1984 12
1985 9
1986 19
1987 12
1988 18
1989 11
1990 19
1991 21
1992 23
1993 26
1994 35
1995 42
1996 50
1997 35
1998 33
1999 39
2000 29
2001 40
2002 30
2003 42
2004 42
2005 45
2006 37
2007 46
2008 32
2009 35
2010 37
2011 29
2012 36
2013 36
2014 20
2015 30
2016 25
2017 28
2018 18
2019 25
2020 23
2021 16
Text availability
Article attribute
Article type
Publication date

Search Results

1,170 results
Results by year
Filters applied: . Clear all
Page 1
Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial.
Groeneweg S, Peeters RP, Moran C, Stoupa A, Auriol F, Tonduti D, Dica A, Paone L, Rozenkova K, Malikova J, van der Walt A, de Coo IFM, McGowan A, Lyons G, Aarsen FK, Barca D, van Beynum IM, van der Knoop MM, Jansen J, Manshande M, Lunsing RJ, Nowak S, den Uil CA, Zillikens MC, Visser FE, Vrijmoeth P, de Wit MCY, Wolf NI, Zandstra A, Ambegaonkar G, Singh Y, de Rijke YB, Medici M, Bertini ES, Depoorter S, Lebl J, Cappa M, De Meirleir L, Krude H, Craiu D, Zibordi F, Oliver Petit I, Polak M, Chatterjee K, Visser TJ, Visser WE. Groeneweg S, et al. Lancet Diabetes Endocrinol. 2019 Sep;7(9):695-706. doi: 10.1016/S2213-8587(19)30155-X. Epub 2019 Jul 31. Lancet Diabetes Endocrinol. 2019. PMID: 31377265 Free PMC article. Clinical Trial.
Adjunctive thyroid hormone treatment in rapid cycling bipolar disorder: A double-blind placebo-controlled trial of levothyroxine (L-T(4) ) and triiodothyronine (T(3) ).
Walshaw PD, Gyulai L, Bauer M, Bauer MS, Calimlim B, Sugar CA, Whybrow PC. Walshaw PD, et al. Bipolar Disord. 2018 Nov;20(7):594-603. doi: 10.1111/bdi.12657. Epub 2018 Jun 4. Bipolar Disord. 2018. PMID: 29869405 Free PMC article. Clinical Trial.
OBJECTIVES: This report describes the first comparative double-blind, placebo-controlled trial of levothyroxine (L-T(4) ) and triiodothyronine (T(3) ) as adjunctive treatments in rapid cycling bipolar disorder. ...
OBJECTIVES: This report describes the first comparative double-blind, placebo-controlled trial of levothyroxine (L-T(4) ) and triiodothyr
Treatment of hypothyroidism with levothyroxine plus liothyronine: a randomized, double-blind, crossover study.
Kaminski J, Miasaki FY, Paz-Filho G, Graf H, Carvalho GA. Kaminski J, et al. Arch Endocrinol Metab. 2016 Nov-Dec;60(6):562-572. doi: 10.1590/2359-3997000000192. Epub 2016 Aug 25. Arch Endocrinol Metab. 2016. PMID: 27982198 Clinical Trial.
OBJECTIVE: To compare the effects of a unique fixed combination levothyroxine/liothyronine (LT4/LT3) therapy in patients with primary hypothyroidism. ...
OBJECTIVE: To compare the effects of a unique fixed combination levothyroxine/liothyronine (LT4/LT3) therapy in patients with primary …
Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial.
Pantos C, Kostopanagiotou G, Armaganidis A, Trikas A, Tseti I, Mourouzis I. Pantos C, et al. Trials. 2020 Jun 26;21(1):573. doi: 10.1186/s13063-020-04474-0. Trials. 2020. PMID: 32586399 Free PMC article. Clinical Trial.
The present study aims to address the efficacy and safety of acute administration of triiodothyronine (T3) in critically ill COVID-19 infected patients requiring mechanical respiratory support or Extra Corporeal Membrane Oxygenation (ECMO). ...Estimated recruitment will fi …
The present study aims to address the efficacy and safety of acute administration of triiodothyronine (T3) in critically ill COVID-19 …
Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial.
Appelhof BC, Fliers E, Wekking EM, Schene AH, Huyser J, Tijssen JG, Endert E, van Weert HC, Wiersinga WM. Appelhof BC, et al. J Clin Endocrinol Metab. 2005 May;90(5):2666-74. doi: 10.1210/jc.2004-2111. Epub 2005 Feb 10. J Clin Endocrinol Metab. 2005. PMID: 15705921 Clinical Trial.
Controversy remains about the value of combined treatment with levothyroxine (LT4) and liothyronine (LT3), compared with LT4 alone in primary hypothyroidism. ...
Controversy remains about the value of combined treatment with levothyroxine (LT4) and liothyronine (LT3), compared with LT4 alone in …
Phase I randomized trial of liothyronine for remyelination in multiple sclerosis: A dose-ranging study with assessment of reliability of visual outcomes.
Wooliscroft L, Altowaijri G, Hildebrand A, Samuels M, Oken B, Bourdette D, Cameron M. Wooliscroft L, et al. Mult Scler Relat Disord. 2020 Jun;41:102015. doi: 10.1016/j.msard.2020.102015. Epub 2020 Feb 20. Mult Scler Relat Disord. 2020. PMID: 32120028 Clinical Trial.
BACKGROUND: Thyroid hormone promotes remyelination in multiple sclerosis (MS) animal models through a variety of mechanisms. Liothyronine (L-T3) is a short-acting thyroid hormone with demonstrated safety and tolerability for short-term and chronic use in euthyroid adults w …
BACKGROUND: Thyroid hormone promotes remyelination in multiple sclerosis (MS) animal models through a variety of mechanisms. Liothyronine
Oral Triiodothyronine Supplementation Decreases Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.
Marwali EM, Caesa P, Darmaputri S, Sani AA, Roebiono PS, Fakhri D, Djer MM, Munasir ZM, Batubara JRL, Satroasmoro S, Portman MA, Haas NA. Marwali EM, et al. Pediatr Cardiol. 2019 Aug;40(6):1238-1246. doi: 10.1007/s00246-019-02143-x. Epub 2019 Jul 15. Pediatr Cardiol. 2019. PMID: 31309235 Clinical Trial.
The oral triiodothyronine for infants and children undergoing cardiopulmonary bypass (OTICC) trial showed that Triiodothyronine (T3) supplementation improved hemodynamic and clinical outcome parameters. ...
The oral triiodothyronine for infants and children undergoing cardiopulmonary bypass (OTICC) trial showed that Triiodothyronine
Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B. Cooper-Kazaz R, et al. Arch Gen Psychiatry. 2007 Jun;64(6):679-88. doi: 10.1001/archpsyc.64.6.679. Arch Gen Psychiatry. 2007. PMID: 17548749 Clinical Trial.
BACKGROUND: Antidepressant treatments that achieve a higher remission rate than those currently available are urgently needed. The thyroid hormone triiodothyronine may potentiate antidepressant effects. OBJECTIVE: To determine the antidepressant efficacy and safety of l
BACKGROUND: Antidepressant treatments that achieve a higher remission rate than those currently available are urgently needed. The thyroid h …
High levels of maternal total tri-iodothyronine, and low levels of fetal free L-thyroxine and total tri-iodothyronine, are associated with altered deiodinase expression and activity in placenta with gestational diabetes mellitus.
Gutiérrez-Vega S, Armella A, Mennickent D, Loyola M, Covarrubias A, Ortega-Contreras B, Escudero C, Gonzalez M, Alcalá M, Ramos MDP, Viana M, Castro E, Leiva A, Guzmán-Gutiérrez E. Gutiérrez-Vega S, et al. PLoS One. 2020 Nov 24;15(11):e0242743. doi: 10.1371/journal.pone.0242743. eCollection 2020. PLoS One. 2020. PMID: 33232364 Free PMC article. Clinical Trial.
1,170 results